Andrew D. Burdick
- Cancer Research top 10%
- Molecular Biology top 10%
- Peroxisome Proliferator-Activated Receptors 4
- RNA Interference and Gene Delivery 3
- Cell death mechanisms and regulation 2
- CRISPR and Genetic Engineering 2
- Metabolism, Diabetes, and Cancer 2
- Biochemistry top 10%
- Toxicology top 10%
-
- Virus-based gene therapy research 2
-
- Drug Transport and Resistance Mechanisms 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Jeffrey M. PetersFrank J. GonzalezMarjorie A. PerazaScott W. BurchielJohn W. DavisKe Jian LiuHonglian ShiLaurie G. Hudson
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Andrew D. Burdick
16 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 255
- Molecular Biology 710
- Health, Toxicology and Mutagenesis 141
- Biochemistry 69
- Toxicology 26
Countries citing papers authored by Andrew D. Burdick
This map shows the geographic impact of Andrew D. Burdick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Burdick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Burdick more than expected).
Fields of papers citing papers by Andrew D. Burdick
This network shows the impact of papers produced by Andrew D. Burdick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Burdick. The network helps show where Andrew D. Burdick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew D. Burdick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2021 | 22 | |
| 4 | 2020 | 2 | |
| 5 | 2014 | 114 | |
| 6 | 2013 | 41 | |
| 7 | 2013 | 2 | |
| 8 | 2007 | 71 | |
| 9 | 2007 | 84 | |
| 10 | 2006 | 38 | |
| 11 | 2005 | 92 | |
| 12 | 2005 | 215 | |
| 13 | 2005 | 131 | |
| 14 | 2003 | 31 | |
| 15 | Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. | 2003 | 162 |
| 16 | Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor alpha production. | 2001 | 46 |
About Andrew D. Burdick
Andrew D. Burdick is a scholar working on Toxicology, Cancer Research and Oncology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), RNA Interference and Gene Delivery (3 papers), Virus-based gene therapy research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Cell death mechanisms and regulation (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer-related Molecular Pathways (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (255 citations), Molecular Biology (710 citations) and Health, Toxicology and Mutagenesis (141 citations). Andrew D. Burdick has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Jeffrey M. Peters, Frank J. Gonzalez, Marjorie A. Peraza, Scott W. Burchiel, John W. Davis, Ke Jian Liu, Honglian Shi, Laurie G. Hudson, Fredine T. Lauer and Dae Joon Kim.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.